These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10968797)

  • 1. Chemotherapy for advanced colorectal cancer.
    Michael M; Zalcberg JR
    BMJ; 2000 Sep; 321(7260):521-2. PubMed ID: 10968797
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of mortality and costs associated with FOLFOX versus FOLFIRI in stage IV colorectal cancer.
    Nelson MA; Shetty S; Kulakodlu M; Harley C; Seal B
    J Med Econ; 2011; 14(2):179-86. PubMed ID: 21319948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAIRO and FOCUS.
    Seymour MT; Punt CJ
    Lancet; 2007 Dec; 370(9603):1904-5; author reply 1905. PubMed ID: 18068509
    [No Abstract]   [Full Text] [Related]  

  • 4. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group.
    Simmonds PC
    BMJ; 2000 Sep; 321(7260):531-5. PubMed ID: 10968812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On 5-fluorouracil therapy of colorectal cancer.
    Jensen SA
    Dan Med J; 2013 Jul; 60(7):B4603. PubMed ID: 23809976
    [No Abstract]   [Full Text] [Related]  

  • 6. The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer.
    Delea TE; Vera-Llonch M; Edelsberg JS; McGarry L; Anton S; Ulcickas-Yood M; Oster G
    Value Health; 2002; 5(1):35-43. PubMed ID: 11873382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Capecitabine in colorectal carcinoma: news from ASCO 2008]].
    Longo F; Mansueto G
    Tumori; 2008; 94(4):suppl 15-23. PubMed ID: 18822712
    [No Abstract]   [Full Text] [Related]  

  • 8. A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in Canada.
    Maroun J; Asche C; Romeyer F; Mukherjee J; Cripps C; Oza A; Skillings J; Letarte J
    Pharmacoeconomics; 2003; 21(14):1039-51. PubMed ID: 13129416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and toxicity spectrum of continuous infusion of 5-fluorouracil compared with bolus administration in advanced colorectal tumors].
    Rödel C
    Strahlenther Onkol; 1999 Jun; 175(6):294-5. PubMed ID: 10392173
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy of advanced colorectal cancer.
    O'Dwyer PJ; Stevenson JP
    Cancer Treat Res; 1998; 98():111-52. PubMed ID: 10326667
    [No Abstract]   [Full Text] [Related]  

  • 11. Mature results of adjuvant colon cancer trials from the fluorouracil-only era.
    Grem JL
    J Natl Cancer Inst; 2004 May; 96(10):727-9. PubMed ID: 15150295
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcomes research in the health-care system: driven by results.
    Shermock KM
    Value Health; 2002; 5(1):3-4. PubMed ID: 11873381
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: impact on disease-free survival and overall survival.
    Zaniboni A
    J Clin Oncol; 1997 Jun; 15(6):2432-41. PubMed ID: 9196159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reader comments on the cost of cancer care.
    Toftbagen C
    Clin J Oncol Nurs; 2006 Feb; 10(1):15; author reply 15-6. PubMed ID: 16482722
    [No Abstract]   [Full Text] [Related]  

  • 15. A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.
    Lloyd Jones M; Hummel S; Bansback N; Orr B; Seymour M
    Health Technol Assess; 2001; 5(25):1-128. PubMed ID: 11990245
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic evaluation of capecitabine as adjuvant or metastatic therapy in colorectal cancer.
    Best JH; Garrison LP
    Expert Rev Pharmacoecon Outcomes Res; 2010 Apr; 10(2):103-14. PubMed ID: 20384557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic palliative chemotherapy with 5-fluorouracil and leucovorin in disseminated colorectal cancer].
    Wiboltt K; Raskov HH
    Ugeskr Laeger; 1999 Jun; 161(25):3827-32. PubMed ID: 10412300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data.
    Guastadisegni C; Colafranceschi M; Ottini L; Dogliotti E
    Eur J Cancer; 2010 Oct; 46(15):2788-98. PubMed ID: 20627535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trials in advanced and metastatic colorectal carcinoma.
    Dangelica MI; Shoup MC; Nissan A
    Surg Oncol Clin N Am; 2002 Jan; 11(1):173-91, ix. PubMed ID: 11928799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of benefit of 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer with microsatellite instability.
    Johnson L; Chu E
    Clin Colorectal Cancer; 2002 Nov; 2(3):146-8. PubMed ID: 12482330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.